Avid Bioservices Inc (CDMO)

[geocappy1]

Have you ever gone back to buy something and it now cost twice as much or more to buy. Real difficult to pay a lot more for something you could have had for half as much.

Agreed. But what I can't figure out is why the deal is not back on the table. FDA gave approval on a very conservative interpretation of the Phase II data. One would imagine that would renew interest in the deal. For that reason, I have questioned whether the class action lawsuit (frivolous as it is) is not holding something up. Pure conjecture. I have no background on whether such a thing would impact due diligence, but I have posed that question here before and nobody seems to have an decisive answer either way. The other possibility (which if recollection serves correct you may have suggested before) is that there is a very big deal on the table. Given the amount of IP involved, negotiations and due diligence might simply take a considerable amount of time to work through.